|
Perry, M E; Levine, A J (1994) P53 and mdm-2: interactions between tumor suppressor gene and oncogene products. Mt Sinai J Med 61:291-9
|
|
Wilson, J B; Ferguson, M W; Jenkins, N A et al. (1993) Transgenic mouse model of X-linked cleft palate. Cell Growth Differ 4:67-76
|
|
Moore, M; Teresky, A K; Levine, A J et al. (1992) p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice. J Virol 66:641-9
|
|
Tevethia, S S; Epler, M; Georgoff, I et al. (1992) Antibody response to human papovavirus JC (JCV) and simian virus 40 (SV40) T antigens in SV40 T antigen-transgenic mice. Virology 190:459-64
|
|
Zambetti, G P; Quartin, R S; Martinez, J et al. (1991) Regulation of transformation and the cell cycle by p53. Cold Spring Harb Symp Quant Biol 56:219-25
|
|
Martinez, J; Georgoff, I; Martinez, J et al. (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5:151-9
|
|
Levine, A J; Momand, J (1990) Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products. Biochim Biophys Acta 1032:119-36
|
|
Wilson, J B; Weinberg, W; Johnson, R et al. (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315-27
|
|
Levine, A J (1988) Oncogenes of DNA tumor viruses. Cancer Res 48:493-6
|
|
Yagaloff, K A; Lozano, G; van Dyke, T et al. (1986) Serotonin 5-HT1C receptors are expressed at high density on choroid plexus tumors from transgenic mice. Brain Res 385:389-94
|
